Charles Schwab Investment Management »

Travere Therapeutics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.8M 540k 8.99
2023-09-30 $5.1M 566k 8.94
2023-06-30 $8.3M 540k 15.36
2023-03-31 $11M 502k 22.49
2022-12-31 $9.7M 463k 21.03
2022-09-30 $11M 463k 24.64
2022-06-30 $11M 470k 24.23
2022-03-31 $12M 472k 25.77
2021-12-31 $14M 458k 31.04
2021-09-30 $11M 464k 24.25
2021-06-30 $9.3M 640k 14.59
2021-03-31 $17M 676k 24.97
2020-12-31 $15M 558k 27.26